Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/41055, first published .
High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study

High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study

High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study

Journals

  1. Evenepoel P, Jørgensen H. Hypocalcemia: a cardiovascular risk factor coming of age?. Nephrology Dialysis Transplantation 2023 View
  2. Ouchi R, Nagao M, Suzuki S, Yamagata T, Chiba M, Kurata N, Usui K, Watanabe T, Koyama K, Okada K. A case with a trend of QT interval prolongation due to the introduction of methadone to a pancreatic cancer patient on levofloxacin. Journal of Pharmaceutical Health Care and Sciences 2024;10(1) View
  3. Hamid A, Pastor Arroyo E, Calvet C, Hewitson T, Muscalu M, Schnitzbauer U, Smith E, Wagner C, Egli-Spichtig D. Phosphate Restriction Prevents Metabolic Acidosis and Curbs Rise in FGF23 and Mortality in Murine Folic Acid–Induced AKI. Journal of the American Society of Nephrology 2024 View